Umed Ibragimov

Dr. Umedjon Ibragimov combines his programmatic expertise and academic scholarship to advance the health of people who use drugs and other populations affected by HIV. He applies rigorous quantitative and qualitative methods, as well as community-based participatory research, to study stigma and other social and structural factors influencing drug- and HIV-related outcomes. Additionally, he utilizes implementation science approaches to improve access to HIV and drug-related services both in the U.S. and globally. Dr. Ibragimov received his MD degree from Tajik State Medical University (1999) and his Master of Public Health (2009) and PhD (2017) degrees from Emory University.

Dr. Ibragimov’s past work focused on exploring the role of structural factors such as economic policies in epidemics of HIV and sexually transmitted infections in large U.S. metropolitan areas. He also studied HIV prevention interventions among people who inject drugs in Eastern Europe and Central Asia, explored the role of stigma and violence as barriers to services for men who have sex with men (MSM) in Tajikistan and advanced the methodology of HIV and substance use research among MSM in China. His current projects involve addressing barriers to the implementation of syringe service programs for people who inject drugs and peer-led interventions for emergency department patients with substance use disorders in the U.S.